3.6500
+0.1100
+(3.11%)
At close: 3:04:06 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Wenxia Zhou | Vice Chairman & GM | -- | -- | 1972 |
| Mr. Dali Chen | CFO & Director | -- | -- | 1962 |
| Mr. Fei Long | Secretary of the Board & Non-Independent Director | -- | -- | 1979 |
Hubei Biocause Pharmaceutical Co., Ltd.
- Sector:
- Financial Services
- Industry: Insurance - Life
- Full Time Employees:
- 1,765
Description
Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. It also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, the company is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. It exports its products to approximately 85 countries, including the United States, the European Union, and internationally. The company is based in Jingmen, China.
Corporate Governance
Hubei Biocause Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
May 30, 2023 at 12:00 AM UTC
Ex-Dividend Date